Navigation Links
Organ Transplant Drug Keeps Immune System in Check
Date:2/3/2010

In lab tests, it fights rejection and reduces need for immunosuppressive meds, study finds

WEDNESDAY, Feb. 3 (HealthDay News) -- Adding a new drug to the heavy regimen of immunosuppressant drugs given to organ transplant recipients not only prevented rejection of the new organ but also cut down on the amount of immunosuppressant drugs needed, a new study finds.

Researchers hope the experimental drug will eventually preclude the need for any immunosuppressant drugs after an organ transplant.

"Current drugs are quite toxic when it comes to long-term survival. There are side effects, and organs suffer because of the drugs," said Dr. Mohanram Narayanan, associate professor of internal medicine at Texas A&M Health Science Center College of Medicine in Temple and chief of clinical transplantation at Scott & White Healthcare. "This is a definite step in the right direction."

"The hope is that this will translate into a new treatment to prevent organ rejection in transplant patients," added Agnes Azimzadeh, second author of a study published Feb. 3 in Science Translational Medicine.

"The other long-term goal is not only to prevent the rejection of organs more efficiently than is done currently but also to induce tolerance to the graft itself," added Azimzadeh, an assistant professor of surgery at the University of Maryland School of Medicine in Baltimore.

"That means that we modulate, we tweak, we educate the immune system of the transplant recipient so it recognizes the graft as [its own] cells rather than recognizing it as foreign. We would educate the immune system so well that at some point we could stop or decrease significantly immunosuppressive drugs that the patient has to take."

Organ transplantation is the only hope for many patients experiencing kidney, heart or other organ failure, but the body's innate immune system perceives the new organ as a threat and sends out immune soldiers to attack it.

As a result, transplant recipients must take immunosuppressive drugs with major toxic side effects for the rest of their lives.

And the organ will eventually be rejected anyway, said the study authors.

Existing drugs aim at the immune system's T cells which, by attacking or not attacking a new organ, can make or break the transplant.

T cells are controlled by two pathways that can activate or inhibit release of the cells.

Current immunosuppressive drugs target both pathways, meaning that T cells can't do their regular job of clearing legitimate threats to the system, making organ recipients vulnerable to infection.

These scientists blocked only one pathway with a more specific antibody, leaving the immune system less reactive to the body's new resident.

None of the monkeys who were given either heart or kidney transplants with the usual immunosuppressive drugs plus the CD28 blocker had rejected their organs three months after receiving the drug.

More information

The United Network for Organ Sharing has more on organ transplantation.



SOURCES: Mohanram Narayanan, M.D., associate professor of internal medicine, Texas A&M Health Science Center College of Medicine, and chief of clinical transplantation, director of nephrology/hypertension, Scott & White Healthcare, Temple, Texas; Agnes Azimzadeh, Ph.D., assistant professor of surgery, University of Maryland School of Medicine, Baltimore; Feb. 3, 2010, Science Translational Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES
2. New Harris Corporation Program Assists Healthcare Organizations in Implementing CONNECT Solution for NHIN Connectivity
3. AT&T Launches Mobile Paging and Group Notification Solution for Healthcare Organizations
4. BMEGateway Celebrates its 20th Anniversary and Welcomes Dr. William Morgan
5. Nationwide Vote to Determine Best Organ Donation-Themed Movie
6. Which Health Care Organizations Are Advancing Consumer Protection and Empowerment?
7. Hacker Attacks Targeting Healthcare Organizations Doubled in the 4th Quarter of 2009 According to SecureWorks Data
8. European Cancer Organization supports a revision of the EU Clinical Trials Directive
9. Ronald McDonald House Charities(R) (RMHC(R)) Awards Nearly $3 Million to Non-Profit Organizations
10. SimpleWebBox Offers Free Websites for Non-Profit Organizations
11. FFCHS Launches Online Petition Against Organized Stalking and Electronic Torture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... Fla. (PRWEB) , ... May 02, 2016 , ... ... fat,” wraps itself around major organs, such as the kidneys, liver and pancreas. ... Robert Drapkin, M.D ., a board-certified physician in Internal Medicine, Medical Oncology and ...
(Date:5/2/2016)... ... May 02, 2016 , ... According to an American Psychological Association ... sexually abused before the age of 18. Of those who survive, many still face ... others. , In her new book, Lyah! Lyah! Pants on Fyah!, she shares ...
(Date:5/2/2016)... ... , ... TeleMedCo™, a new company developing real time technology ... rapid diagnosis, triage and admission of patients leveraging IBM Watson’s software and healthcare ... the first time at GENBAND’s Perspectives16 conference. , TeleMedCo selected GENBAND’s Kandy ...
(Date:5/2/2016)... ... ... Dr. Jonathan Kulbersh of Carolina Facial Plastics isn’t surprised that Charlotte, NC, the city where ... 5 US Cities with the Highest Plastic Rates .” The other cities that made ... calculated using a survey by RealSelf and combining that data with the number ...
(Date:5/2/2016)... ... 2016 , ... For many artists, the act of blending paint is based ... a science. , Using the new, highly precise METTLER TOLEDO ML204T balance to ... and meaning to his works. What’s more, it has allowed him to recreate these ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... April 29, 2016 Acquisition ... Sciences, Product Development Capabilities in North ... Base . Indegene ( http://www.indegene.com ... the acquisition of Skura Corporation,s life science business. ... adaptive sales enablement technology for life science organizations ...
(Date:4/28/2016)... 2016  While Abbott,s announced purchase of St. ... repair and stent business, healthcare research firm Kalorama ... firmly into patient monitoring.  Kalorama said that patient ... areas, with double-digit growth expected the next 5 ... Remote Patient Monitoring . Abbott Laboratories agreed ...
(Date:4/28/2016)... , April 28, 2016 ... insights on healthcare, announced today that it has been ... Cool Vendor in Life Sciences, 2016, ... 2016.  The report focuses on life-science- oriented analytics, algorithms ... from patients and doctors, confirm medication ingestion, and analyze ...
Breaking Medicine Technology: